Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|June 25, 2009
Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitorLucy Garvey, Alan Winston
HIV Clinical Trials|December 23, 2011
Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapyLucy Garvey, Veena Surendrakumar, Alan Winston
International Journal of STD & AIDS|July 4, 2008
Does chronic stress lead to increased rates of recurrences of genital herpes--a review of the psychoneuroimmunological evidence?David Goldmeier, Lucy Garvey, Simon Barton
Current Opinion in Infectious Diseases|December 3, 2019
Interventions to reduce acute hepatitis C virus in HIV-positive MSMTamara Elliott, Graham S Cooke, Lucy Garvey
The Neuroradiology Journal|October 24, 2015
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohortsShivanee Vigneswaran, Jaime H Vera Rojas, Lucy Garvey, et al.
International Journal of STD & AIDS|July 14, 2023
Drug-induced liver injury secondary to increased levonorgestrel exposure in a patient taking ritonavirPhilip D Oddie, Joseph Heskin, Suki Leung, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2015
HIV-1 CNS in vitro infectivity models based on clinical CSF samplesBorja Mora-Peris, Alan Winston, Lucy Garvey, et al.
Medicine|November 26, 2019
Spleen stiffness measurements using point shear wave elastography detects noncirrhotic portal hypertension in human immunodeficiency virusAyesha K Ahmad, Sebastiana Atzori, Simon D Taylor-Robinson, et al.
HIV Clinical Trials|April 16, 2015
Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controlsJane Ashby, Caroline Foster, Lucy Garvey, et al.
AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.
Pageof 2